Siemens promotes breast cancer awareness
October is a Breast Cancer Awareness month. Siemens Healthcare Sector has started a worldwide campaign to increase the public
US FDA nod to Zydus Cadila to sale anti BP drug
Drug firm Cadila Healthcare has got approval from US health regulator to market high blood pressure treatment tablets, Losartan Potassium and Losartan Potassium and HCTZ in the American market, reports media.
MAXimising Benefit : October 2010
EDITORIAL Hospitals Do IT COVER STORY MAXimising Benefits SPOTLIGHT THE ITO DEAL HAS BEEN A POSITIVE LEARNING FOR US Dr […]
Sun gets USFDA nod for generic heart disease drug
Drug maker Sun Pharma recently said it has received a tentative approval from US health regulator to sell a generic version of Crestor tablets, used in the treatment of various heart diseases, in the American market.
Transasia Bio-Medicals acquires a majority stake in US based IVAX Diagnostics
Transasia Bio- Medicals Ltd, one of the leading players in the Clinical Diagnostics Segment of the Indian healthcare sector through its fully owned German subsidiary, Erba Diagnostics Mannheim GmbH has acquired a majority stake in US based company IVAX Diagnostics, Inc.
New one-dose malaria drug discovered
Researchers have discovered a promising new malaria drug with the potential to treat resistant strains of the deadly disease in a single dose, according to a study published recently in the journal Science.
NEWS REVIEW
[This article was published in the September 2010 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
The Union ministry of home affair�s (MHA) directorate of forensic science (DFS) has set the ball rolling for the establishment of a hi-tech Central Forensic Science Laboratory (CFSL) on a 25-acre campus at Wadgaon Maval, about 25 kms from Pune, along the Pune-Mumbai highway, media reports.
Prolor Biotech cleared by FDA for US Phase II HGH Trials
Prolor Biotech Inc (PBTH), the biopharma firm utilising a proprietary CTP technology to commercialise longer-acting, biologically improved versions of existing therapeutics, reported receiving FDA regulatory clearance recently for Phase II clinical trials of hGH-CTP, the Company
Common treatment protocol for the countrymen
The health ministry has planned to standardise common set of protocols for treatment across the country. For this the ministry has set up an expert panel to draft a set of norms for unified treatment standards expected to be implemented in next three to four months and in hospitals and healthcare service centres in one-two years.
Joint Commission International leads 33 partners and sponsors to the Hospital Management Asia Conference in Seoul
Joint Commission International once again demonstrates its strong support of Asia’s premier educational conference for hospital managers as a Strategic Partner. HMA, now on its ninth year will be held at the Grand Hilton Seoul, Korea on August 19 & 20, 2010.
Bridging the gap in medical education : Prof A K Agarwal, Indira Gandhi National Open University (IGNOU), India
It is very crucial to bridge the gap in the context of medical education, where many of the emerging and demanding courses are not present in the conventional courses currently.
